AWP Litigation Increases As Justice Dept. Sues Roxane For Price Inflation
Executive Summary
Another lawsuit has been added to the tangle of litigation over average wholesale drug pricing
You may also be interested in...
AWP Litigation: Three More Companies Ink Deals With DoJ; Roxane Sets A Record
The heavy docket of average wholesale price cases got a bit lighter as three pharma companies agreed to pay $421 million to settle claims they inflated the AWP of numerous drugs, thus increasing reimbursement levels.
AWP Litigation: Three More Companies Ink Deals With DoJ; Roxane Sets A Record
The heavy docket of average wholesale price cases got a bit lighter as three pharma companies agreed to pay $421 million to settle claims they inflated the AWP of numerous drugs, thus increasing reimbursement levels.
AWP Litigation Takes New Twist As Abbott Seeks Sanctions Against DoJ
Abbott is pursuing a new tactic in litigation over its average wholesale drug pricing. It is accusing the Department of Justice of failing to preserve evidence critical to its defense